Allstate Corp Buys 10,942 Shares of Agilent Technologies, Inc. $A

Allstate Corp boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 113.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,582 shares of the medical research company’s stock after purchasing an additional 10,942 shares during the period. Allstate Corp’s holdings in Agilent Technologies were worth $2,801,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Flynn Zito Capital Management LLC lifted its position in Agilent Technologies by 3.2% during the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after purchasing an additional 69 shares during the period. Gabelli Funds LLC increased its holdings in Agilent Technologies by 1.1% during the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after buying an additional 74 shares during the last quarter. Fiduciary Trust Co increased its holdings in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC increased its holdings in Agilent Technologies by 1.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after buying an additional 79 shares during the last quarter. Finally, Freestone Capital Holdings LLC raised its holdings in Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after purchasing an additional 84 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on A shares. Royal Bank Of Canada initiated coverage on Agilent Technologies in a report on Wednesday. They issued an “outperform” rating and a $153.00 target price on the stock. UBS Group reduced their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. TD Cowen reduced their price target on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Morgan Stanley reduced their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $162.40.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Q2 fiscal 2026 estimates, posting adjusted EPS of $1.49 versus the $1.40 consensus and revenue of $1.83 billion versus $1.80 billion expected, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its FY 2026 profit forecast, signaling confidence in demand for lab tools and equipment used in research and diagnostics. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Agilent’s FY 2026 guidance came in slightly above consensus, while its Q3 revenue outlook matched expectations and EPS guidance was near the top of the range, reinforcing stable near-term execution. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Analysts turned more constructive, with RBC initiating/covering the stock at outperform and Baird lifting its price target, suggesting more upside if the company keeps delivering. Benzinga analyst update
• Neutral Sentiment: Agilent’s latest results also showed GAAP EPS of $1.20 and highlighted solid profitability metrics, but these were secondary to the stronger non-GAAP performance and guidance update.

Agilent Technologies Stock Up 0.6%

Shares of A stock opened at $115.82 on Thursday. The company has a market capitalization of $32.73 billion, a price-to-earnings ratio of 25.57, a PEG ratio of 2.42 and a beta of 1.22. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company’s fifty day moving average price is $114.99 and its 200-day moving average price is $128.79. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company’s revenue was up 10.0% on a year-over-year basis. During the same period last year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.